logo

For the Inventor, By the Inventor

Hatboro, PA, United States of America

Kenneth M Snader

USPTO Granted Patents = 16

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal13 out of 344 
 
Smithkline Corporation
 patents
silverMedal3 out of 207 
 
Smithkline Beckman Corporation
 patents

Years Active: 1976-1988

Loading Chart...
16 patents (USPTO):Explore Patents
1. 4778846 - Affinity chromatography sorbent (1988-10-18),
2. 4667024 - Process for the preparation of purified vancomycin class antibiotics (1987-05-19),
3. 4385122 - Anthracycline antibiotics produced by streptosporangium fragile (1983-05-24),
4. 4293546 - Anthracycline antibiotics produced by Streptosporangium fragilis Shearer (1981-10-06),
5. 4292305 - Antiallergic imidodisulfamides (1981-09-29),
6. 4165365 - Substituted 2H-pyran-2,6(3H)-dione derivatives (1979-08-21),
7. 4160021 - Substituted 2H-pyran-2,6(3H)-dione derivatives (1979-07-03),
8. 4127646 - Substituted 2H-pyran-2,6(3H)-dione derivatives (1978-11-28),
9. 4122201 - Method of treating asthma with 4,6-dihydroxy-2H-pyran-2-ones (1978-10-24),
10. 4117226 - Substituted 3-cinnamoyl-2H-pyran-2,6(3H)-diones (1978-09-26),
11. 4083952 - Substituted aurones (1978-04-11),
12. 4032652 - Substituted 2H-pyran-2,6(3H)-dione derivatives, pharmaceutical (1977-06-28),
13. 4025642 - Substituted 2H-pyran-2, 6(3H)-dione derivatives (1977-05-24),
14. 4025614 - Substituted 2H-pyran-2,6 (3H)-dione derivatives useful in treatment of (1977-05-24),
15. 4015009 - Pharmaceutical compositions comprising substituted (1977-03-29),

Title: Discovering the Innovations of Kenneth M. Snader

Introduction

Kenneth M. Snader is a notable inventor based in Hatboro, Pennsylvania, with an impressive portfolio that includes 16 patents. His contributions to the field of pharmaceutical sciences focus on innovative processes for the isolation and purification of vancomycin class antibiotics. His work has significantly impacted the way these crucial antibiotics are developed and used in medical treatments.

Latest Patents

Among his latest patents, Snader has developed an affinity chromatography sorbent and a process for the preparation of purified vancomycin class antibiotics. Both patents utilize a novel process involving affinity chromatography through the formation of a sorption complex between the antibiotic and an immobilizing ligand derived from -D-alanyl-D-alanine or -X-D-alanyl-D-alanine, where X represents an amino acid radical. The innovative affinity chromatography sorbent disclosed in these patents serves as a vital tool for enhancing the efficiency and effectiveness of antibiotic purification.

Career Highlights

Kenneth Snader's professional journey includes significant roles at renowned companies such as SmithKline Corporation and SmithKline Beecham Corporation. His career reflects a strong commitment to advancing pharmaceutical research and the development of antibiotic treatments, showcasing his dedication to improving public health.

Collaborations

Throughout his career, Snader has collaborated with notable professionals, including Chester Rhodes Willis and Chester R. Willis. These partnerships have fueled his research endeavors and contributed to the successful completion of several innovative projects in the field of antibiotic development.

Conclusion

Kenneth M. Snader exemplifies the impact that a dedicated inventor can have on the field of pharmaceuticals. His numerous patents and collaborative efforts with esteemed colleagues highlight a relentless pursuit of innovation aimed at improving the purification of vancomycin class antibiotics. As the field continues to evolve, Snader's contributions will undoubtedly play a crucial role in the ongoing battle against bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…